AOSOP3 EFFICACY OF CONCURRENT CHEMORADIOTHERAPY WITH CAPECITABINE AND CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Results. Higher sensitivity of diagnosis for HCC with GdEOB-DTPA MRI (88.64%) and Sonazoid-CEUS (84.09%) was observed compared with 64-MDCT (70.45%) for all HCC nodules, albeit insignificantly different. For nodules of 2 cm or less in diameter, compared with 64-MDCT (60.98%), GdEOB-DTPA MRI (82.93%, p 0.05). When nodules were more than 2 cm in diameter, there were no significant differences in diagnostic sensitivity between the imaging modalities. When the combination modality of GdEOB-DTPA and Sonazoid-CEUS was evaluated, the diagnostic sensitivity was increased to 93.5% in HCC nodules of 2 cm or less in diameter. Discussion.Gd-EOB-DTPA and Sonazoid-CEUS forHCC as liverspecific contrast agents showed higher sensitivity of diagnosis compared with 64-MDCT. The combined modality of Gd-EOBDTPA with Sonazoid-CEUS is a better choice for diagnosis of HCC. Funding. Nil. The authors declared no conflicts of interest.